Warberg Asset Management »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Warberg Asset Management

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Warberg Asset Management from 13F filings

Historical chart of Warberg Asset Management investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Warberg Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Warberg Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $7.2M 5.1M 1.41
2025-06-30 $5.8M 5.1M 1.14

More positions owned by Warberg Asset Management

Spdr S&p 500 Etf Tr Put Put Option
Invesco Qqq Tr Put Put Option
Seagate Hdd Cayman Note 3.500% 6/0 (Principal)
Sea Note 2.375%12/0 (Principal)
Western Digital Corp Note 3.000%11/1 (Principal)
Cnx Res Corp Note 2.250% 5/0 (Principal)
Axon Enterprise Note 0.500%12/1 (Principal)
Live Nation Entertainment In Note 3.125% 1/1 (Principal)
Microchip Technology Note 1.625% 2/1 (Principal)
Box Note 1/1 (Principal)
Integer Hldgs Corp Note 2.125% 2/1 (Principal)
Occidental Pete Corp *w Exp 08/03/202 (OXY.WS)
Macom Tech Solutions Hldgs I Note 0.250% 3/1 (Principal)
Stride Note 1.125% 9/0 (Principal)
Workiva Note 1.125% 8/1 (Principal)

View all positions for Warberg Asset Management

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

Millennium Management
LMR Partners
Calamos Advisors
Camden Asset Management
Balyasny Asset Management
DLD Asset Management
Point72 Asset Management
Davidson Kempner Capital Management
Jpmorgan Chase & Co
Jain Global
Nuveen
Lazard Asset Management
State Street Corporation
Absolute Investment Advisers
Citadel Advisors

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1